Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model

Focal Radiation Therapy Combined with 4-1BB Activation and CTLA-4 Blockade Yields Long-Term Survival and a Protective Antigen-Specific Memory Response in a Murine Glioma Model

Glioblastoma (GBM) is the most common malignant brain tumor in adults and is associated with a poor prognosis. Cytotoxic T lymphocyte antigen -4 (CTLA-4) blocking antibodies have demonstrated an ability to generate robust antitumor immune responses against a variety of solid tumors. 4-1BB (CD137) is...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Zineb Belcaid, Jillian Phallen, Jing Zeng, Alfred P. See, Dimitrios Mathios, C. Gottschalk, Sarah E. Nicholas, M. Kellett, Jacob Ruzevick, Christopher M. Jackson, Emilia Albesiano, Nicholas M. Durham, Xiaobu Ye, Phuoc T. Tran, Betty Tyler, John Wong, Henry Brem, Drew M. Pardoll, Charles G. Drake, Michael Lim
Hōputu: Artigo
Reo:Ingarihi
I whakaputaina: 2014
Urunga tuihono:https://doi.org/10.1371/journal.pone.0101764
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0101764&type=printable
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ipurangi

https://doi.org/10.1371/journal.pone.0101764
https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0101764&type=printable

Ngā tūemi rite